Swayze Eric
Reporting owner on Forms 3, 4 and 5, CIK 1791058.
Swayze Eric reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| IONS · IONIS PHARMACEUTICALS INCCIK 874015 | officer (EVP Research) | 1 | 2026-10-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| IONS · IONIS PHARMACEUTICALS INCCommon Stock | 2026-10-16 | S sold | -53 | $43.5389 | 390 | Form 4 |
| IONS · IONIS PHARMACEUTICALS INCCommon Stock | 2026-10-15 | M exercised | +125 | $0 | 443 | Form 4 |
| IONS · IONIS PHARMACEUTICALS INCCommon Stock, holding | 21,759 | Form 4 | ||||
| IONS · IONIS PHARMACEUTICALS INCRestricted Stock Unit, derivative | 2026-10-15 | M exercised | -125 | $0 | 486 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000874015-26-000266 | IONIS PHARMACEUTICALS INC | 2026-10-19 |